Vargas EJ, Rizk M, Gomez-Villa J, Edwards PK, Jaruvongvanich V, Storm AC, et al
SeekPeptides members can access detailed transition protocols and ongoing guidance for this post-medication phase, which is often the most challenging part of the entire GLP-1 journey
The companys leadership, led by new CEO Maziar "Mike" Doustdar, cited a "painful transition" as the primary reason for the downgrade, acknowledging that the era of $1,000-per-month GLP-1 prices in the U.S
#longevity #geroscience #peptides #artificialintelligence #drugdiscovery LG AI Research D&D Pharmatech To view or add a comment, sign in Confused by names like BPC-157, GHK-Cu, MOTS-c, and Tesamorelin